17 Start-up
Companies

$24,181,132
Total Funding

5 Clinical
Trials Started

25 Licensed
Technologies

REM’s Vision

Accelerate therapeutic delivery innovation and translation to treat disease. REM’s initiative will achieve this goal, which will position Georgia as a leading innovation hub in this intellectual space and benefit Georgia’s knowledge economy, by fostering interdisciplinary and multi-institutional collaborations and supporting research ranging from fundamental to translational to positively impact human health.

News & Events

Growing Back the Lymph System
The study, published in a Nature journal, provides hope for cancer-related lymphedema
‘Natural killer’ cells could halt Parkinson’s progression
Researchers at the University of Georgia’s Regenerative Bioscience Center and their colleagues have found that “natural killer” white blood cells could guard against the cascade of cellular changes that lead to Parkinson’s disease and help stop its progression.
Developing a Better Model
Dixon collaborates with UGA researchers to uncover potential early signs of lymphedema
Setting the Standards for New Therapeutics
Georgia Tech and CMaT host ASTM International workshop focused on cell and tissue manufacturing
King of Hearts
Mick Jagger owes some thanks for the fact he’s alive and strutting to Ajit Yoganathan and his lab crew